ArticleCureus2025

Apixaban- and Rivaroxaban-Associated Bleeding: A Retrospective Analysis Using the FDA Adverse Event Reporting System.

Ilana K Logvinsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.